FAM90A21P

Across TCGA pan-cancer cohorts, FAM90A21P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated FAM90A21P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher FAM90A21P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM90A21P expression acts as an unfavorable survival marker.

OV, UCEC, and SARC are the cancer types where FAM90A21P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.241	0.693	.002	108	view →
UCEC	OS	Tertile	All	0.170	0.873	<.001	108	view →
SARC	OS	Tertile	All	0.032	0.861	<.001	36	view →
THCA	DFS	Tertile	All	0.277	0.851	.004	12	view →
THYM	DFS	Tertile	All	0.107	0.884	.001	9	view →
LGG	OS	Tertile	All	0.324	0.799	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FAM90A21P–OV (OS)

Open the OV breakdown →